Despite major advances in care, nearly half of U.S. adults live with some form of cardiovascular disease or stroke, according to the American Heart Association(R), a relentless force changing the ...

Brainomix, a global leader and pioneer of AI-powered imaging tools in stroke and lung fibrosis, has been named a winner in ...

The hospital has continued to see growth in scans at multiple locations – meaning it is holistically seeing more patients who ...

Despite making up half of the 64 million people living with heart failure, patients with this common form have no access to ...

New study has discovered a groundbreaking technology that is showing remarkable success in significantly reducing bad ...

The American College of Cardiology has partnered with OpenEvidence to speed up the translation of research into clinical implementation.  Through the strategic partnership, OpenEvidence users will ...

New research reveals how gut microbes may influence the development of coronary artery disease, the world’s leading killer.

Amgen's Repatha cholesterol drug significantly reduces the risk of first cardiac events by 25% in at-risk patients.

JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced highlights from the 2025 Transcatheter Cardiovascular Therapeutics (TCT) ...

The device may help boost early detection of HFrEF for people living in low-resource settings where echo is scarce.

An international investigation confirms that beta-blockers, prescribed routinely for four decades, do not provide benefits to ...

The American College of Cardiology (ACC) and OpenEvidence have announced a strategic partnership to integrate generative AI ...